- Home
- TOP vs ESLA Comparison
TOP vs ESLA Comparison
Compare TOP & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- ESLA
- Stock Information
- Founded
- TOP 2015
- ESLA 2021
- Country
- TOP Hong Kong
- ESLA United States
- Employees
- TOP N/A
- ESLA N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOP Finance
- ESLA Health Care
- Exchange
- TOP Nasdaq
- ESLA Nasdaq
- Market Cap
- TOP 45.2M
- ESLA 37.3M
- IPO Year
- TOP 2022
- ESLA N/A
- Fundamental
- Price
- TOP $1.28
- ESLA $0.81
- Analyst Decision
- TOP
- ESLA Strong Buy
- Analyst Count
- TOP 0
- ESLA 1
- Target Price
- TOP N/A
- ESLA $16.00
- AVG Volume (30 Days)
- TOP 52.1K
- ESLA 47.2K
- Earning Date
- TOP 04-15-2025
- ESLA 05-14-2025
- Dividend Yield
- TOP N/A
- ESLA N/A
- EPS Growth
- TOP N/A
- ESLA N/A
- EPS
- TOP N/A
- ESLA N/A
- Revenue
- TOP $2,730,890.00
- ESLA N/A
- Revenue This Year
- TOP N/A
- ESLA $402.53
- Revenue Next Year
- TOP N/A
- ESLA N/A
- P/E Ratio
- TOP N/A
- ESLA N/A
- Revenue Growth
- TOP N/A
- ESLA N/A
- 52 Week Low
- TOP $1.13
- ESLA $0.63
- 52 Week High
- TOP $3.30
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- TOP 49.08
- ESLA 38.27
- Support Level
- TOP $1.21
- ESLA $0.73
- Resistance Level
- TOP $1.35
- ESLA $1.02
- Average True Range (ATR)
- TOP 0.07
- ESLA 0.11
- MACD
- TOP 0.01
- ESLA -0.01
- Stochastic Oscillator
- TOP 63.16
- ESLA 21.32
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.